Find your path to Thomas
433 people in our graph can introduce you to Thomas.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jonathan Userovici to introduce you to Thomas
You →Jonathan · together at Bioptimus (2024–2026) →Thomas
Ask Jamie Chen to introduce you to Thomas
You →Jamie · 3 people · together at Bioptimus →Thomas
Ask Sam Okafor to introduce you to Thomas
You →Sam · 3 people · together at Owkin →Thomas
Sign up to find every way you can get introduced to Thomas
- Your email: the people you already email who know Thomas
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Thomas
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Thomas Clozel is a medical doctor and the CEO and co-founder of Owkin, a company focused on applying artificial intelligence to drug development and patient care.
Founder at Owkin
Intro paths
In turn, Thomas can intro founders to Owkin's investors below.
Owkin's investors · 10
Co-founders at Owkin
Experience
- OWKINCEO and Co-foundercurrent2016 — presentNew York City Metropolitan Area
- BioptimusNon operational cofounder and Board Dlrectorcurrent2024 — present
- XPRIZEBrain trustcurrent2024 — presentRégion de la baie de San Francisco
- Université Paris-SaclayMember Board of Directorscurrent2024 — presentVille de Paris, Île-de-France, France
- Cure51Non operational cofoundercurrent2024 — present
- EQT GroupAdvisorcurrent2025 — present
- Sofinnova PartnersVenture advisorcurrent2022 — presentVille de Paris, Île-de-France, France
- GRACEAdvisorcurrent2023 — present
- Fragment (YC S23)Seed Investor2023
- Osium AI (YC S23)Seed Investor2023
- 8400 The Health NetworkGlobal expert2023District de Tel Aviv, Israël
- DioxycleInvestor2022
- KanjiSeed Investor2022
- Spot - justspot.ioSeed Investor2021
- Resilience careSeed Investor2021
- Patch BiosciencesSeed Investor2020
- CHU Henri Mondor de CréteilClinical Assistant Professor2012 — 2014Paris Area, France
- Weill Cornell Medical CollegeResearch Fellow2009 — 2012
- Hôpital Necker-Enfants MaladesInternat2006 — 2012
- Biochimie, Cellules, Cibles Thérapeutiques (BC2T)Master 2 parcours recherche2009 — 2010
Skills & more
+8 more
Cell CultureLife SciencesArtificial IntelligenceEntrepreneuriatHealthClinicalRecherche cliniqueSanté publiqueLanguages English · French · German
From Thomas's professional profile.
Deals · 1
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Frequently asked questions
- Who is Thomas Clozel?
- Thomas Clozel is a medical doctor and the CEO and co-founder of Owkin, a company focused on applying artificial intelligence to drug development and patient care.
- Where does Thomas Clozel work?
- Thomas Clozel is Founder of Owkin and Founder, Chief Executive Officer at Owkin.
- What companies did Thomas Clozel found?
- Thomas Clozel founded Owkin.
- Where did Thomas Clozel go to school?
- Thomas Clozel studied at Joan & Sanford I. Weill Medical College of Cornell University (research fellowship, Hematology-oncology); Icahn School of Medicine at Mount Sinai (Clinical rotation, Neurology Department).
Founder mafias
Plug and Play Ventures mafia164
Also came through, then founded or led a company.
Icahn School of Medicine at Mount Sinai mafia25
Also came through, then founded or led a company.
Sofinnova Partners mafia15
Also came through, then founded or led a company.
Joan & Sanford I. Weill Medical College of Cornell University mafia12
Also came through, then founded or led a company.
EQT Group mafia10
Also came through, then founded or led a company.
Same school
Also attended Joan & Sanford I. Weill Medical College of Cornell University29
+ 23 more
Also attended Icahn School of Medicine at Mount Sinai39
+ 33 more
Shared employers
Also worked at Bioptimus8
+ 2 more
Also worked at XPRIZE48
+ 42 more
Also worked at 8400 The Health Network20
+ 14 more
Also worked at Weill Cornell Medical College55
+ 49 more

















































































